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Abstract
The two antagonistic systems of angiotensin converting enzyme (ACE)-1 and 
ACE-2 are in the “eye of the hurricane” of severe acute respiratory syndrome 
coronavirus (SARS-CoV-2). The receptor of the SARS-CoV-2 is the same as ACE-
2, which causes its under-expression after binding it, followed by the internaliza-
tion of the complex virus-ACE-2. ACE-2 have multiple functions with specially 
relevance in cardiovascular diseases. Furthermore, the non-enzymatic role of 
ACE-2 gives rise to a Hartnup disease, a phenocopy involving microbiota. With 
this chapter, we intent to explore the key pathways involved in SARS-CoV-2 infec-
tion, from the host perspective, considering our hypothesis related to transporter 
of neutral amino acids, which includes tryptophan precursor of serotonin and 
kynurenine.
Keywords: severe acute respiratory syndrome coronavirus (SARS-CoV-2),  
renin-angiotensin system, tryptophan precursors, microbiome, genetic susceptibility
1. Background
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), initiated in 
Wuhan in China, revisited 17 years later an outbreak that started in 2002 in China 
caused by a virus very similar to SARS-CoV-2 [1]. Identification and sequencing 
of the virus responsible for COVID-19 determined that it was a novel coronavirus 
that shared 88% sequence identity with two bat-derived SARS-like CoV, suggesting 
it’s origin in bats [2]. Additionally, it was shown that this coronavirus, which was 
termed 2019-nCoV or SARS-CoV-2, shared 79.5% sequence identity with SARS-
CoV [2].
After inhalation of SARS-CoV-2, it invades nasal epithelial cells (superior 
respiratory tract) and type II pneumocytes through binding the SARS spike pro-
tein to angiotensin-converting enzyme 2 (ACE-2) receptors [3]. This complex is 
proteolytically processed by transmembrane protease serine 2 (TMPRSS2), leading 
to cleavage of ACE-2 and activation of the spike protein, thereby facilitating viral 
entry into the target cell. For SARS-CoV-2 entry into a host cell, its spike protein 
needs to be cleaved by cellular proteases at 2 sites, termed S protein priming by the 
Please use Adobe Acrobat Reader to read this book chapter for free.
Just open this same document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Connection...Acrobat is locking documen loading.com
r
File cannot be found.
Some RNA Viruses
2
serine protease TMPRSS2, then the viral and cellular membranes can fuse [4]. It has 
been suggested that cells in which both ACE-2 and TMPRSS2 are expressed are most 
susceptible to entry by coronaviruses from the SARS family, among which is the 
virus described to cause SARS and, also SARS-CoV-2 [4, 5].
In relation to the mechanism of infection, the infected cells trigger the host’s 
immune response, and the inflammatory cascade is initiated by innate immune cells, 
being the host environment extremely important for internalization and multiplica-
tion of the virus [6]. Possible mechanisms of receptor and signaling mechanisms 
responsible for induction of inflammatory mediators, such as cytokines or chemo-
kines, may be related to the release of danger signal molecules, like certain cytokines, 
or may be involve a different recognition pathway mediated by immune cells through-
out known pattern recognition receptors, such as toll-like receptors (TLRs) [7].
The heterologous protection against infections through epigenetic, transcrip-
tional, and functional reprogramming of innate immune cells may contribute to 
different susceptibility to severity of SARS-CoV-2 [7, 8]. Furthermore, the changes 
in metabolic and endocrine pathways associated with SARS-CoV-2 infection may 
untangle a more profound understanding of this disease and contribute to a more 
adequate response.
2. Host systemic reactions of SARS-CoV-2 infection
Although the SARS-CoV-2 infection is highly associated to respiratory infec-
tion, it is also true, that this infection reflects a systemic involvement with multiple 
symptoms, including fever, persistent dry cough, shortness of breath, chills, 
muscle pain, headache, loss of taste or smell, and gastrointestinal symptoms [9]. 
Interestingly, according to the clinical features of individuals affected with SAR-
CoV-2, a significant proportion of patients initially present some atypical gastroin-
testinal symptoms such as diarrhea, nausea, and vomiting [10].
Coronaviruses are one of many pathogens known to cause postinfectious olfac-
tory dysfunction, nasal epithelial cells and mainly goblet cells in a high expression 
patterns of the ACE-2 receptor, which is required for SARS-CoV-2 entry. Olfactory 
dysfunction and anosmia are highly implicated in SARS-CoV-2 infection. The 
inclusion of loss of smell or taste among these symptoms follows the emergence 
of evidence suggesting that SARS-CoV-2 frequently impairs the sense of smell. 
Olfactory disfunction, defined as reduced or distorted ability to smell during 
sniffing (orthonasal olfaction) or eating (retronasal olfaction), is often reported in 
mild or even asymptomatic cases [11]. There have also been reports of acute-onset 
(sudden) anosmia, sometimes in the absence of other symptoms, as a marker of 
SARS-CoV-2 [12].
Disruption of cells in the olfactory neuroepithelium may result in inflammatory 
changes that impair olfactory receptor neuron function, cause subsequent olfac-
tory receptor neuron damage, and/or impair subsequent neurogenesis [13]. Such 
changes may cause temporary or longer-lasting olfactory disease.
Inflammatory signaling molecules are released by infected cells and alveolar 
macrophages in addition to recruited T lymphocytes, monocytes, and neutrophils. 
Subsequently the integrity of the alveolar-capillary membrane is compromised 
by the inflammatory response triggered by SARS-CoV-2 [14]. In the late stage, 
pulmonary edema can fill the alveolar spaces with hyaline membrane formation, 
compatible with early-phase acute respiratory distress syndrome [14], bradykinin 
may contribute to this pulmonary edema [15].
Another contribution for systemic reaction of SARS-CoV-2 infection is the 
nasal gene expression of ACE-2. Indeed, the lower rates of SARS-CoV-2 infection 
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were found in children. From nasal epithelial samples collected as part of a study 
involving patients with asthma from 2015 to 2018, a comprehending a cohort of 
305 patients aged 4 to 60 years, evidenced that the lower expression of ACE-2 in 
the nasal epithelium were found in younger children and ACE-2 expression was 
higher with each subsequent age group after adjusting for sex and asthma [16]. Yet, 
a recent study bring some data that children may be a potential source of contagion 
in the SARS-CoV-2 in spite of milder disease or lack of symptoms, and immune 
dysregulation is implicated in severe post-infectious multisystem inflammatory 
syndrome in children [17].
3.  Implications of angiotensin-converting enzymes and renin-
angiotensin system in SARS-CoV-2
Overexpression of human ACE-2 enhanced disease severity of SAR-CoV-2 
infection, being the lung injury aggravated by the presence of SARS-CoV spike. 
Interestingly, in mice model, the lung injury was attenuated by blocking the renin-
angiotensin pathway and depended on ACE-2 expression [18].
In contrast to other coronaviruses, SARS-CoV-2 became highly lethal because 
the virus deregulates a lung protective pathway. About 83% of cells that express 
ACE-2 were alveolar epithelial type II cells (AECII), suggesting that those cells can 
serve as a reservoir for viral invasion [19]. In addition, gene ontology enrichment 
analysis showed that the expression ACE-2 by AECII have high levels of multiple 
viral process-related genes, including regulatory genes for viral processes, viral 
life cycle, viral assembly, and viral genome replication, suggesting that the ACE2-
expressing AECII facilitate viral replication in the lung [20].
Expression of the ACE-2 receptor is also found in many extrapulmonary tissues 
including heart, kidney, and intestine [21]. In human lung, the ACE-2 is expressed 
in endothelial and smooth muscle cells of large and small blood vessels, and in 
alveolar and bronchial epithelial cells.
Contrarily to ACE-1, the ACE-2 is barely present in the circulation, but widely 
expressed in mentioned organs. Although ACE-2 is more related to the physiopa-
thology of SARS-CoV, ACE-1 converts angiotensin I into angiotensin Ang II, then 
ACE-2 break down angiotensin II into molecules that counteract angiotensin II, 
but if the virus occupies the ACE-2 ‘receptor’ on the surface of cells, then its role is 
blunted [22]. Angiotensin I, can cause vasoconstriction, inflammation, and fibrosis 
by signaling through angiotensin II type 1 receptors. ACE-2 cleave angiotensin II 
to angiotensin 1–7, which can suppress inflammation and fibrosis and generate 
vasodilation by binding to the mas receptor (Figure 1a) [23–26].
Moreover, ACE-2 is a negative regulator of the renin-angiotensin system (RAS), 
and functions as the key SARS coronavirus receptor and stabilizer of neutral 
amino acid transporters [27]. As previously mentioned, the ACE-2 catalyzes the 
conversion of angiotensin II to angiotensin 1–7, thereby counterbalancing ACE 
activity, and converts angiotensin I to generate angiotensin 1–9 [3]. The RAS is an 
acute phase pathway involved in the multisystemic response of cardiovascular and 
hematopoietic systems, maintenance of blood pressure homeostasis, as well as fluid 
and salt balance in mammals [28]. Abnormal activation of RAS has been associ-
ated with the pathogenesis of cardiovascular and renal diseases such as hyperten-
sion, myocardial infarction and heart failure. Therefore, these disorders share 
 underlying pathophysiology related to the RAS and COVID19 that may be clinically 
insightful [29].
Cardiovascular disease and pharmacologic RAS inhibition both increase ACE-2 
levels, which may increase the virulence of SARS-CoV-2 within the lung and 
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heart, since the receptor of the two viruses is the same enzyme protein of the cell 
membrane [32]. Conversely, mechanistic evidence from related coronaviruses 
suggests that SARS-CoV-2 infection may downregulate ACE-2, leading to toxic over 
accumulation of angiotensin II that induces acute respiratory distress syndrome and 
fulminant myocarditis [33]. Therefore, RAS inhibition could mitigate this effect 
[34]. ACE-2 genetic variants may determine the circulating angiotensin 1–7 levels 
only in hypertensive females that probably had dose effects related to the localiza-
tion in the X Chromosome of ACE-2 gene [35].
The bradykinin-kallikrein system can further contribute to local vascular leak-
age leading to angioedema, due to a local vascular problem because of activation 
of bradykinin 1 receptor (B1R) and B2R on endothelial cells in the lungs. The RAS 
is needed to inactivate des-Arg9 bradykinin, which is a potent ligand of the B1R 
[15]. In the late stage, pulmonary edema can fill the alveolar spaces with hyaline 
membrane formation, compatible with early-phase acute respiratory distress 
syndrome.
Other aspect to be pointed out is collectrin (Figure 1a), an homolog of ACE-2, 
that have been identified as essential molecules required for expression of neutral 
amino acid transporters on the cell surface of epithelial cells. Collectrin (Tmem27) 
is a transmembrane glycoprotein that is highly expressed in the kidney and vascular 
endothelium [36]. Furthermore, concordant with metabolic and endocrine changes 
associated with SARS-CoV-2 infection, collectrin might also have a role in insulin 
secretion in pancreatic β-cells and/or growth of islet cells [37].
Detailing the mechanism of ACE-1 and its possible role in SARS-CoV-2, ACE-1 
has pleiotropic actions involving the cardiovascular and hematopoietic systems 
[23–25]. The two catalytic domains of ACE-1 has different affinities for its pro-
miscuous substrates respectively in the N domain for goralitide or N-acetyl-seryl-
aspartyl-lysyl-proline (NacSDKP), an inhibitor of hematopoiesis and fibrogenesis 
and that have influence on blood pressure predominantly the C-domain for 
Angiotensin I or for both domains as is the case of Bradykinin [25, 27].
Figure 1. 
Integrative schematic diagram of the role of ACE (ACE-1), ACE-2 and collectrin in the renin–angiotensin 
system (a) (adapted from [30]) and the impact of RAS inhibition in SARS-CoV-2 infection (b) [31].
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Unpublished results from our group reflected an inverse correlations of ACE 
activity with antioxidant erythrocyte and plasma activity enzymes, and direct cor-
relation with lower relative concentrations of glutathione associated to proinflam-
matory conditions like obesity and several autoimmune diseases (Figure 2).
In terms of detection of SARS-CoV-2, the RT-PCR is a cheaper, easier and short 
turn-around time method for detection of RNA component of SARS-CoV-2, in 
upper respiratory samples, comparing with sequencing technology. Considering the 
Figure 3. 
Distribution of ACE activity according to ACE (a) and SERT (serotonin transporter) (b) genotypes.
Figure 2. 
Correlation between ACE and transmembrane redox system (a), erythrocyte methaemoglobin reductase (b), 
plasma epinephrine oxidase (c) and with plasma ratio of oxidized glutathione to reduced glutathione (d).
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genetic variability, the ACE-1 Insertion/Deletion (I/D) functional polymorphism  
influence its activity in plasma as it was reported by us and other authors (Figure 3a) 
[23, 38]. However, the ACE I/D polymorphism is not associated with increased 
susceptibility or poor outcome after SARS-CoV-1 infection [39]. Paradoxically, in 
studies on longevity from our and other groups, individuals with DD genotype, 
with higher activities of ACE, are more represented in centenarians [40, 41].
The response to this pathway when exaggerated, as is the case of the SARS-
CoVs infections, causes intense inflammatory and fibrogenic processes. On the 
contrary, the system initiated by ACE-2 also has pleiotropic antagonistic actions of 
the classic system and it has an anti-inflammatory and anti-fibrogenic system [42]. 
Furthermore, both systems have functional polymorphic genetic variations [23, 38, 
39, 43–45].
Genetic polymorphisms in the RAS are putative markers prone to affect the 
clinical course of SARS-CoV-2 infection. Cao et al. in 2020 suggested that ACE-2 
and SARS-CoV-2 associated frequencies among populations can be justified by 
allele sequences distributions. The greatest are in East Asians populations with 
higher expressions in tissues that suggest different susceptibilities or response to 
SARS-CoV-2 in different ecosystems [44].
4.  Correlations of immune response, acute phase proteins and 
tryptophan precursors in SARS-CoV-2 infection
As previously mentioned, the major clinical complication in patients with 
SARS-CoV-2 is respiratory failure due to local hyperinflammation and acute 
respiratory distress syndrome. The pathophysiology of these complications has 
strong similarities to other severe viral lung infections, such as influenza, and other 
infections caused by coronaviruses (SARS and Middle East respiratory syndrome). 
An important mechanism mediating lung pathology in these infections is a cytokine 
storm leading to the so-called “macrophage activation syndrome” with crucial role 
for monocytes and macrophages [46, 47].
Accordingly with the major clinic complications of this infection, this extreme 
inflammation compromises the respiratory performance, which often requires 
ventilator support or, even, extracorporeal membrane oxygenation [48]. However, 
in approximately 80% of cases, the latter did not prevent mortality, owing to insuf-
ficient lung perfusion, which could be explained by developing thromboembolic 
complications. In this context, clinical trials are underway to determine whether 
anticoagulants (e.g., heparin) or profibrinolytic drugs (e.g., tissue plasminogen 
activator) ameliorate severe infection with thromboembolic complications [30, 49].
From the inflammatory perspective, these infection leads to changes in circulat-
ing concentrations of proinflammatory cytokines, such as interleukin (IL)-6, tumor 
necrosis factor (TNF), monocyte chemoattractant protein-1 (MCP-1), macrophage 
inflammatory protein 1-alpha (MIP1A), and interferon gamma-induced protein 
10 (IP10), comparing patients in intensive care unit (ICU) and to those who do not 
need treatment in the ICU, although the concentrations of some of these cytokines 
are only moderately increased [50]. This strong increase in systemic inflammation 
is associated with endothelial dysfunction, increased coagulation activity reflected 
by elevated d-dimers [50] and hyperactive CCR6 + Th17+ T cells locally in the lung 
[9]. The increase in systemic concentrations of proinflammatory cytokines was 
minimal, even during days 7–9, when the patient was symptomatic. This suggests 
that a mild course of infection is associated with few systemic inflammatory effects. 
Still, the hyper-inflammation occurs in SARS-CoV-2 and is associated with worse 
outcomes [48].
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Gender differences have been widely discussed in different pathologies, indeed 
these differences may reflect sex chromosome genes and sex hormones, includ-
ing estrogens, progesterone, and androgens, with implications to the differential 
regulation of immune responses between the genders [51]. In studies of hyperten-
sion, there is a clear difference between genders taking on account the distribution 
of ACE-2 genetic polymorphisms associated levels of angiotensin 1-7 [52].
Concerning SARS-CoV-2 infection, a male bias in mortality has emerged in 
the COVID-19 pandemic, which is consistent with the pathogenesis of other viral 
infections. Biological gender differences may manifest themselves in susceptibility 
to infection, early pathogenesis, innate viral control, adaptive immune responses 
or the balance of inflammation and tissue repair in the resolution of infection [53]. 
The differences in immune response according with gender, suggest less robust 
T cell-mediated immunity in male patients with worsening outcome and higher 
innate cytokine activity, compared to female patients [54].
Evidence reflected the gender as an important driver of risk of mortality and 
response to the SARS-CoV-2 pandemic. The sex differences in SARS-CoV-2 mor-
tality, severity and recovery, may underly implications of cardiovascular disease 
(CVD) risk factors, reflecting a plausible biological reasons for this sex difference 
in SARS-CoV-2 infection [55]. This disproportionate death ratio in men may partly 
be explained by their relatively higher contribution of pre-existing diseases (i.e., 
CVD, hypertension, diabetes, and chronic lung disease), higher risk behaviors 
(i.e., smoking and alcohol use), and occupational exposure [55]. There may be 
other behavioral and social differences that favor women, with prior studies sug-
gesting women are more likely than men to follow hand hygiene practices and seek 
preventive care [55].
The host metabolism supports viral pathogenesis by fueling viral prolifera-
tion, by providing free amino acids and fatty acids as building blocks. Alterations 
in tryptophan metabolism and kynurenine pathway regulates inflammation and 
immunity [56]. The indolamine-2, 3-dioxygenase (IDO) is an intracellular, non-
secreted enzyme, which catabolizes kynurenine from tryptophan with interesting 
role in viral and bacterial infections [57]. Since many microbial organisms rely on 
the essential amino acid tryptophan, its degradation by IDO-expressing cells of the 
innate immune system was favored as the major IDO-mediated mechanism against 
infections [58]. In infectious disease states, IDO has been shown to exert pleiotropic 
effects, even with opposing outcomes. IDO prevents viral spread and from host 
perspective also acts to suppress immune reactions thereby promoting infectious 
diseases [56, 59].
Tryptophan metabolism was the top pathway affected by SARS-CoV-2. As 
such, focused analysis of this pathway highlighted significant decreases (inversely 
proportional to IL-6 concentration) in tryptophan, serotonin, and indolepyruvate 
levels. In contrast, increases in kynurenine, kynurenic acid, picolinic acid, and nico-
tinic acid suggested hyperactivation of the kynurenine pathway [58]. Furthermore, 
the levels of IL-6 in serum were significantly different from SARS-Cov-2 patients 
and controls and they were correlated with changes in tryptophan metabolism [58]. 
From this study, targeted metabolomics analyses were performed on sera using 
ultra-high-pressure liquid chromatography-mass spectrometry (UHPLC–MS), 
highlighting significant associations of COVID-19 and IL-6 levels with amino acid 
metabolism, purines, acylcarnitines, and fatty acids [58]. Dysregulation of nitrogen 
metabolism was also seen in infected patients, with altered levels of most amino 
acids, along with increased markers of oxidant stress (e.g., methionine sulfoxide, 
cystine), proteolysis, and renal dysfunction (e.g., creatine, creatinine, polyamines). 
Increased circulating levels of glucose and free fatty acids were also observed, 
consistent with altered carbon homeostasis. Interestingly, metabolite levels in these 
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pathways correlated with clinical laboratory markers of inflammation (i.e., IL-6 
and C-reactive protein) and renal function (i.e., blood urea nitrogen). This initial 
observational study identified amino acid and fatty acid metabolism as correlates of 
SARS-CoV-2 [58].
In our group, we also demonstrated that a functional variable number of tandem 
repeats (VNTR) genetic polymorphism of serotonin transporter, whose expression 
is activated by IL-1, has some relation with the ACE serum levels that can be associ-
ated with unbalanced ACE-ACE-2 system (Figure 3b) [38].
Polymorphisms in genes coding for IL-10, TNF-alpha and IL-6 influence circu-
lating levels, and behave as promoters of severe systemic inflammatory response 
that can probably has an interindividual and gender dependent impact [53].
At the other end of the iceberg, the immunocompromised patients could be 
protected against SARS-CoV-2, since unlike other common viruses, coronaviruses 
have not shown to cause more severe disease in immunosuppressed patients, at 
least statistically significant [60]. Our own immune response appears to be the 
main driver of lung tissue damage during infection. Starting around the 2nd week 
of symptoms, patients experience a “storm of cytokines” – autoimmune reaction, 
where your body over-reacts and in attacking coronavirus, your lungs get caught 
in the body immunologic response [47, 61]. In the first week of the illness it’s the 
virus itself that’s triggering most of your symptoms, but then in severe cases, it’s our 
own inflammatory responses that takes over in causing the most of the damage. So 
this “storm of cytokines” is killing our immune cells, therefore, could patients with 
immunosuppressive profile be protected from this reciprocal attack?
The children account for less than 2% of identified cases of SARS-CoV-2 [62]. 
Interestingly, young children, including infants who are more susceptible to other 
infections, have milder symptoms and less severe SARS-CoV-2. Nevertheless, chil-
dren seem to have similar rates of becoming infected compared with middle-aged 
adults following close contact with a person infected with SARS-CoV-2 [33].
Long-term boosting of innate immune responses, also termed “trained immu-
nity,” by certain live vaccines (Bacillus Calmette–Guérin - BCG, oral polio vaccine, 
measles) induces heterologous protection against infections through epigenetic, 
transcriptional, and functional reprogramming of innate immune cells [63].
5.  Endocrine and metabolic contributions in SARS-CoV-2 infection: ACE-2 
downregulation in SARS-CoV-2 as phenocopy of Hartnup disease
Epidemiological data showed that the elderly and those with co-morbidities 
(diabetes, obesity, and cardiovascular, respiratory, renal, and lung diseases) are 
most susceptible to COVID-19 and more likely to suffer from the most severe 
disease complications [64]. Viral infections mobilize free fatty acids to support 
capsid-associated membrane formation, which was described for other coronavi-
ruses and is explained, in part, by activating phospholipase A2, a target amenable to 
pharmacological intervention [65].
Hartnup disease is a condition caused by the body’s inability to absorb certain 
protein building blocks (amino acids) from the diet. As a result, affected individu-
als are not able to use these amino acids to produce other substances, such as vita-
mins and proteins. Most people with Hartnup disease are able to get the vitamins 
and other substances they need with a well-balanced diet [27, 66].
Individuals with Hartnup disease have high levels of various amino acids in 
their urine (aminoaciduria). For most affected individuals, this is the only sign of 
the condition. However, in other cases, individuals have episodes exhibiting other 
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signs, which can include skin rashes, difficulty of coordination of movements (cer-
ebellar ataxia), and psychiatric symptoms, such as depression or psychosis. These 
episodes are typically temporary and are often triggered by intercurrent infection, 
stress, nutrient-poor diet, or fever. These features tend to go away once the trigger 
is changed, although the aminoaciduria remains. In affected individuals, signs and 
symptoms most commonly occur in childhood [67, 68].
As previously mentioned, the two antagonistic systems ACE, ANG II, AT1R and 
ACE2, ANII 1–7 are in the “hurricane eye” of SARS-CovV-2 and the non-enzymatic 
role of ACE-2 give rise to Hartnup disease phenocopy. ACE-2 is also a stabilizing 
protein (very similar to collectrin in kidney) of the neutral amino acid transporter 
mutated in the Hartnup disease [27].
In mice with ACE-2 deletion in the small intestine, there was also a decrease in 
tryptophan absorption secondary to the lower expression of the neutral amino acid 
transporter accompanied by a phenotype very similar to that of Hartnup’s disease 
phenotypes [69]. This situation can be caused by SARS-COVs and probably explains 
the gastro intestinal symptoms sometimes associated with those viral infections. In 
this case, it may be the result of the accumulation of nephrotoxic and pro-inflam-
matory pulmonary products (indole derivatives) or lack of anti-inflammatory 
kynurenines (IDO derivatives), as a consequence of dysbiosis at large intestine 
resulting from the lack of absorption of several neutral and aromatic amino acids 
namely tryptophan [70, 71].
6.  New highlights of possible microbioma association to SARS-CoV-2 
infection
Concordantly to exposed in this chapter, the SARS-CoV-2 is more than a severe 
respiratory infection and actually integrate a multisystemic coordination. Metabolic 
syndrome and microbiome had been associated in intervention from ACE-2. This 
relation has an explanation that is now much more clarified and that goes through 
the IDO derivatives (Kynurenines) associated with aryl hydrocarbon receptor 
(AhR) and anti-inflammatory response Th22 [56].
The rationale of the non-enzymatic role of ACE-2 to serotonin and IDO deriva-
tives to kynurenines has an explanation based in the activation of AhR functions 
by these tryptophan metabolites as they activates anti-inflammatory cytokines 
that may counteract the SARS-CoV-2 gastrointestinal and pulmonary symptoms 
characterized by a “cytokine storm” [72]. This can have their origin in the dysbiosis 
related to the tryptophan catabolism in indol derivatives by unbalanced Lacobacillus 
spp (decreased) specially in high salt microenvironment characteristic of western 
pattern diets [71, 73, 74].
Importantly, ACE-2 is highly expressed on the luminal surface of intestinal 
epithelial cells, functioning as a co-receptor for nutrient uptake, in particular for 
amino acid resorption from food [75]. Therefore the intestine might also be a major 
entry site for SARS-CoV-2 and the infection might have been initiated by eating 
food from the Wuhan market, the putative site of the outbreak. Whether SARS-
CoV-2 can indeed infect the human gut epithelium has important implications 
for fecal–oral transmission and containment of viral spread. Moreover, the ACE-2 
tissue distribution in other organs could explain the multi-organ dysfunction 
observed in patients [66, 71, 76, 77]. Any perturbation in host-microbiota crosstalk 
can be an initiating or re-enforcing factor in SARS-CoV-2 pathogenesis.
Some bacteria produce bioactive neurotransmitters that have previously been 
proposed to modulate nervous system activity and behaviors of their host. A large 
Please use Adobe Acrobat Reader to read this bo k chapter for free.
Just open this sam  document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Conne tion..Acroba  is locking documen loading.co
r
File cannot be found.
Some RNA Viruses
10
array of metabolites drives the crosstalk between the host and its microbiome. The 
three currently most studied categories of metabolites involved in host-microbiota 
interactions are short-chain fatty acids produced by bacteria from the fermentation 
of fibbers, bile acids produced in the liver and transformed by the gut microbiota 
before re-affecting the host, and tryptophan metabolites, which are the topic of 
this review [72].
Tryptophan is an essential aromatic amino acid composed of a b carbon con-
nected to the 3 position of an indole group and it is a biosynthetic precursor of 
a large number of microbial and host metabolites [78]. It’s metabolism follows 
three major pathways in the gastrointestinal tract: the direct transformation of 
Tryptophan into several molecules, including ligands of the (AhR) by the gut 
microbiota [78]; the kynurenine pathway in both immune and epithelial cells via 
IDO-1 [79]; and the serotonin (5-hydroxytryptamine [5-HT]) production pathway 
in enterochromaffin cells via Tryptophan hydroxylase 1 (TpH1) [72]. The AhR is 
implicated in lung inflammation [80].
The gut microbiota influences the health of the host, especially with regard to 
gut immune homeostasis and the intestinal immune response. In addition to serving 
as a nutrient enhancer, L-tryptophan plays crucial roles in the balance between 
intestinal immune tolerance and gut microbiota maintenance.
7. Final marks
These lessons derived of SARS-CoVs infections outbreaks (2003 and 2019) can 
explain the role of the two antagonistic RASs pathways on the hypoxic pulmonary 
vasoconstriction an homeostatic mechanism in response to alveolar hypoxia sec-
ondary to acute lung injury in SARS, optimizing ventilation, perfusion and systemic 
oxygen delivery. Moreover, the new knowledge about the role of RAS proteins, 
namely, ACE-2 in gut with pleiotropic actions on the metabolism of tryptophan in 
the crosstalk microbiota–intestine, intestine-kidney and probably intestine-lung 
can help in designing new, based on probiotics and prebiotics or repurposing 
ancient therapies for disorders involving those organ crosstalk resultant physio 
pathologies.
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